Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis–Infected Macrophages, Produce Interferon-γ, and Kill Intracellular Bacteria
and Kill Intracellular Bacteria. PLoS Pathog 4(12): e1000239. doi:10.1371/journal.ppat.1000239
Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis- Infected Macrophages, Produce Interferon-c, and Kill Intracellular Bacteria
Isabel Sada-Ovalle 0 1
Asako Chiba 0 1
Adaena Gonzales 0 1
Michael B. Brenner 0 1
Samuel M. Behar 0 1
JoAnne L. Flynn, University of Pittsburgh School of Medicine, United States of America
0 Funding: This work was supported by National Institutes of Health grants R01 HL80312 and HL080330 to SMB
1 1 Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School , Boston , Massachusetts, United States of America, 2 Immunochemistry Department, National Institute of Respiratory Diseases , Mexico City , Mexico
Cellular immunity to Mycobacterium tuberculosis (Mtb) requires a coordinated response between the innate and adaptive arms of the immune system, resulting in a type 1 cytokine response, which is associated with control of infection. The contribution of innate lymphocytes to immunity against Mtb remains controversial. We established an in vitro system to study this question. Interferon-c is produced when splenocytes from uninfected mice are cultured with Mtb-infected macrophages, and, under these conditions, bacterial replication is suppressed. This innate control of bacterial replication is dependent on CD1d-restricted invariant NKT (iNKT) cells, and their activation requires CD1d expression by infected macrophages as well as IL-12 and IL-18. We show that iNKT cells, even in limiting quantities, are sufficient to restrict Mtb replication. To determine whether iNKT cells contribute to host defense against tuberculosis in vivo, we adoptively transferred iNKT cells into mice. Primary splenic iNKT cells obtained from uninfected mice significantly reduce the bacterial burden in the lungs of mice infected with virulent Mtb by the aerosol route. Thus, iNKT cells have a direct bactericidal effect, even in the absence of synthetic ligands such as a-galactosylceramide. Our finding that iNKT cells protect mice against aerosol Mtb infection is the first evidence that CD1d-restricted NKT cells mediate protection against Mtb in vivo.
-
Cells of the innate immune system use several receptor systems
to recognize pathogens and act as the first line of defense against
infection. In contrast, the expression of clonal antigen receptors
and the capacity to differentiate into memory cells distinguish B
and T lymphocytes as the central components of the adaptive
immune system. Certain T subsets, such as cd T cells and NKT
cells, have features of innate immune cells including a partially
activated phenotype, a rapid response following detection of
infected cells, and the modulation of other cell types [1]. Together
with NK cells, these cell subsets are functionally defined as innate
lymphocytes. While innate lymphocytes serve important roles in
host resistance to different infections, it remains controversial
whether these cells contribute to immunity against Mycobacterium
tuberculosis (Mtb) infection.
Following Mtb infection, NK cells become activated and are
early and rapid producers of interferon-c (IFN-c), a cytokine
critical for the activation of macrophages (MQ) [2,3]. However,
mouse models in which NK cells are defective or are depleted in
vivo have failed to show that NK cells are essential for immunity to
tuberculosis [3]. Similarly, cd T cells are frequently activated by a
variety of pathogens including Mtb [4]. Mice lacking cd T cells
succumb more rapidly than control mice following intravenous
challenge with virulent Mtb; however, such a difference has not
been observed following infection by the aerosol route [5,6].
Although cd T cells may not be required for optimum control of
bacterial replication following pulmonary infection, cd T cell
deficient mice form disorganized granulomas dominated by foamy
MQ and granulocytes instead of lymphocytes [6]. Similarly, while
CD1d-restricted NKT cells rapidly produce large amounts of
IFNc when activated and play a role in granuloma formation under
certain conditions, there is little evidence to support their
requirement for optimum immunity against Mtb infection,
although their pharmacological activation confers a significant
survival advantage to susceptible mouse strains [714].
The mouse model of tuberculosis has been useful in delineating
how different cell types contribute to immunity against Mtb. Many
important components of the human immune response to Mtb were
first identified or have been successfully modeled in the mouse
including the critical role of IL-12, IFN-c, TNF, and CD4+ T cells.
CD4+ T cells have unambiguously been identified as the most
important lymphocyte subset in the mouse for mediating protection.
However, the dominant role of CD4+ T cells may obscure the
contribution of other immune mechanisms. Factors such as
inoculum size, Mtb strain virulence, and experimental variability
limit the dynamic range of the end points measured and reduce the
capacity to detect subtle defects in immunity. We established an in
vitro model to address whether innate lymphocytes have a role in
immunity against Mtb. In our model, splenocytes obtained from
uninfected mice are cultured with primary MQ infected with
virulent Mtb. Under these conditions, splenocytes secrete IFN-c,
Host resistance to Mycobacterium tuberculosis (Mtb)
requires a coordinated response by the different
components of the immune system. We established an in vitro
model to study the contribution of innate lymphocytes to
immunity against Mtb. When co-cultured with
Mtbinfected macrophages, splenocytes from uninfected mice
become activated and suppress bacterial replication. By
fractionating the different splenocyte cell populations, we
discovered that the invariant NKT (iNKT) cell is essential for
suppressing intracellular bacterial replication. iNKT cells,
which are conserved in rodents and humans, recognize
lipids presented by the antigen-presenting molecule
CD1d. While we had previously shown that iNKT
celldeficient mice are not more susceptible to tuberculosis, a
potential contribution of iNKT cells during the early phase
of immunity may have been masked. To address this issue,
we showed that highly purified iNKT cells were sufficient
to reduce the lung bacterial burden of mice infected with
virulent Mtb. This is the first evidence that CD1d-restricted
iNKT cells play a physiological role in mediating protection
against aerosol Mtb infection in vivo. Thus, by being an
early producer of interferon-g and suppressing intracellular
bacterial growth, iNKT cells function as an important part
of the early immune response against Mtb.
stimulate NOS2 upregulation and NO production, and suppress
intracellular Mtb replication. In this report, we identify the cellular
mechanism that mediates this innate effector function against the
intracellular human pathogen Mtb.
Splenocytes from Nave Mice (...truncated)